Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

53.61
Delayed Data
As of Dec 02
 +0.51 / +0.96%
Today’s Change
50.90
Today|||52-Week Range
85.83
-28.17%
Year-to-Date
How Beaten-Down Mallinckrodt Can Turn Things Around
Dec 02 / MotleyFool.com - Paid Partner Content
Mallinckrodt (MNK) Tops on Earnings & Sales in Q4
Nov 29 / Zacks.com - Paid Partner Content
4 Stocks with Low Price-to-Cash-Flow Ratio to Buy Now
Dec 01 / Zacks.com - Paid Partner Content
Intellipharmaceutics Submits NDA for Pain Treatment Rexista
Nov 28 / Zacks.com - Paid Partner Content
Why Mallinckrodt, Mechel PAO, and Newpark Resources Slumped Today
Nov 29 / MotleyFool.com - Paid Partner Content
Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?
Nov 23 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
Nov 29 / Zacks.com - Paid Partner Content
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Nov 20 / MotleyFool.com - Paid Partner Content
Mallinckrodt Shares Tank, Despite Better-Than-Expected Earnings
Nov 29 / TheStreet.com - Paid Partner Content